Patient-Friendly Explanation

Interleukin-6 is a chemical messenger the body makes during inflammation, and fat tissue produces a lot of it. When levels stay high over time, the body becomes less sensitive to insulin, which helps explain why excess weight is linked to type 2 diabetes and heart disease.

Clinical Definition

IL-6 is a pleiotropic cytokine secreted by adipose-tissue macrophages and adipocytes, and by contracting skeletal muscle as a myokine; in obesity, expanded visceral fat raises circulating IL-6, which increases hepatic C-reactive protein production, impairs insulin signalling through JAK-STAT/SOCS3 pathways and promotes lipolysis and hepatic glucose output. A significant share of circulating IL-6 in obesity comes from adipose tissue, and levels fall with weight loss, regular exercise and improved glycaemic control.

Why It Matters

IL-6 is a marker of the low-grade inflammation that connects excess fat to metabolic disease, so it is increasingly interpreted alongside CRP when tracking whether weight loss is genuinely improving metabolic health.